Indication
Hemolytic anemia due to pyruvate kinase deficiency
Hemolytic anemia due to pyruvate kinase deficiency is an inherited, autosomal recessive metabolic disorder affecting red blood cells, caused by mutations in the *PKLR* gene. Read more about Hemolytic anemia due to pyruvate kinase deficiency
2 drugs 1 manufacturers
Drugs that treat it
Common Hemolytic anemia due to pyruvate kinase deficiency therapies.
PYRUKYND (mitapivat sulfate)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonHemolytic anemia due to pyruvate kinase deficiency is an inherited, autosomal recessive metabolic disorder affecting red blood cells, caused by mutations in the *PKLR* gene.
Deficient activity of the glycolytic enzyme pyruvate kinase impairs adenosine triphosphate (ATP) production in mature erythrocytes, compromising cellular membrane integrity and resulting in premature extravascular hemolysis, predominantly within the spleen.
Clinically recognized as a leading cause of hereditary nonspherocytic hemolytic anemia, it exhibits broad phenotypic severity that spans from mild, fully compensated hemolysis to life-threatening neonatal anemia requiring frequent transfusions.
Defining clinical features and complications include chronic pallor, fatigue, scleral icterus, jaundice, splenomegaly, cholelithiasis, and systemic iron overload.
- nih.gov
Hemolytic anemia due to pyruvate kinase deficiency is an inherited, autosomal recessive metabolic disorder affecting red blood cells, caused by mutations in the *PKLR* gene Clinically recognized as a leading cause of hereditary nonspherocytic hemolytic anemia, it exhibits broad phenotypic severity that spans from mild, fully compensated hemolysis to life-threatening neonatal anemia requiring frequent transfusions
- nih.gov
Hemolytic anemia due to pyruvate kinase deficiency is an inherited, autosomal recessive metabolic disorder affecting red blood cells, caused by mutations in the *PKLR* gene Deficient activity of the glycolytic enzyme pyruvate kinase impairs adenosine triphosphate (ATP) production in mature erythrocytes, compromising cellular membrane integrity and resulting in premature extravascular hemolysis, predominantly within the spleen
- orpha.net
Hemolytic anemia due to pyruvate kinase deficiency is an inherited, autosomal recessive metabolic disorder affecting red blood cells, caused by mutations in the *PKLR* gene Deficient activity of the glycolytic enzyme pyruvate kinase impairs adenosine triphosphate (ATP) production in mature erythrocytes, compromising cellular membrane integrity and resulting in premature extravascular hemolysis, predominantly within the spleen Clinically recognized as a leading cause of hereditary nonspherocytic ...
- nih.gov
Deficient activity of the glycolytic enzyme pyruvate kinase impairs adenosine triphosphate (ATP) production in mature erythrocytes, compromising cellular membrane integrity and resulting in premature extravascular hemolysis, predominantly within the spleen Defining clinical features and complications include chronic pallor, fatigue, scleral icterus, jaundice, splenomegaly, cholelithiasis, and systemic iron overload
- youtube.com
Deficient activity of the glycolytic enzyme pyruvate kinase impairs adenosine triphosphate (ATP) production in mature erythrocytes, compromising cellular membrane integrity and resulting in premature extravascular hemolysis, predominantly within the spleen
Personalize your experience
Follow Hemolytic anemia due to pyruvate kinase deficiency and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.